Skip to main content
UC Davis Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center

News releases

April 2014arrow

UC Davis personalizing outreach to address Asian cancer health disparities

April 11, 2014

In an effort to reduce cancer health disparities among Asian-Americans, UC Davis Comprehensive Cancer Center now offers individual, in-language education and culturally sensitive materials for every Asian-American cancer patient.

March 2014arrow

Time, trust and transparency keys to minority biospecimen collection

March 26, 2014

Blood and tumor specimen collection from cancer patients is critical to research into new, more personally targeted therapies. But biospecimen collection among diverse populations lags far behind that of whites. [Chinese, Vietnamese and Spanish]

UC Davis physician featured in national health equity project

March 24, 2014

UC Davis professor Christopher Bowlus of the Division of Gastroenterology and Hepatology, and his liver cancer disparity research, are featured on the Health Equity Research Snapshot of the Association of American Medical Colleges (AAMC).

Nine-year effort concludes to fund breast cancer endowment at UC Davis

March 21, 2014

After nine years and countless fund-raising events, the Placer Breast Cancer Endowment on Thursday reached its goal of $1.5 million for breast cancer research at UC Davis Comprehensive Cancer Center.

Potential lung cancer vaccine shows renewed promise

March 20, 2014

Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. The study also found that radiation treatments did not significantly impair the immune response. The paper was published on March 10 in the journal Cancer Immunology Research, an American Association for Cancer Research (AACR) publication.

UC Davis faculty drive efforts to improve CT safety

March 19, 2014

UC Davis clinicians and physicists have recommended new strategies to make computed tomography (CT) safer, including adoption of a new metric for dose measurement, ways to manage exposure protocols that differ by CT brand and specific approaches to reduce exposure during needle biopsies. The recommendations are detailed in papers published in the March issue of the Journal of the American College of Radiology (JACR).

Minority clinical trials participation and analysis still lag 20 years after federal mandate

March 18, 2014

Twenty years after Congress mandated that research funded by the National Institutes of Health include minorities, less than 5 percent of trials participants are non-white, and less than 2 percent of clinical cancer research studies focus on non-white ethnic or racial groups, UC Davis researchers have found. [Chinese, Spanish, Korean, Vietnamese]

Joint cancer center study finds barriers to minority clinical trial participation

March 18, 2014

A new study involving researchers from UC Davis and four other National Cancer Institute-designated cancer centers reveals important barriers that limit minority group participation in cancer clinical trials, findings that will be used to refine and launch more effective strategies to assure that more minorities benefit from clinical trials.

UC Davis nursing school hopes to improve care for cancer patients with social network

March 14, 2014

Several chemotherapy patients at the UC Davis Comprehensive Cancer Center will be invited to use tablets with a unique social networking tool as part of their treatment plan.

UC Davis researchers one step closer to ovarian cancer marker

March 10, 2014

The hunt is on to find biomarkers that detect cancer, but it’s a challenging process. Early successes often are followed by heartbreaking failures.

Bone turnover markers predict prostate cancer outcomes

March 7, 2014

Biomarkers for bone formation and resorption predict outcomes for men with castration-resistant prostate cancer, a team of researchers from UC Davis and their collaborators have found.

January 2014arrow

Bruce Hammock receives 2014 Brodie Award

January 23, 2014

Bruce D. Hammock, UC Davis Distinguished Professor of Entomology, has received the 2014 Bernard B. Brodie Award from The American Society for Pharmacology and Experimental Therapeutics (ASPET).

James Purdy receives MD Anderson Distinguished Alumnus Award

January 23, 2014

James A. Purdy, UC Davis professor emeritus in the UC Davis Department of Radiation Oncology, has been given the Distinguished Alumnus Award from the University of Texas MD Anderson Cancer Center.

December 2013arrow

Detecting gastric cancer early -- it's in the sugars

December 20, 2013

Gastric cancer kills more than 700,000 people each year, mostly in Latin America, Asia and Eastern Europe. Though the disease is quite treatable when caught early, symptoms are indistinct and late detection leads to high mortality. The five-year survival rate in the United States is 26.9 percent.

Survival rates have not improved for metastatic prostate cancer

December 18, 2013

Since the prostate specific antigen (PSA) test was introduced in the late 1980s, prostate cancer mortality has dropped by more than 40 percent. However, there has been tremendous controversy over whether the PSA test has caused that decline.  In a newly published study, UC Davis researchers suggest that PSA screening likely plays an important role. [en español]   

Hybrid clotting factor means fewer injections, better disease control for hemophilia patients

December 12, 2013

A Phase III clinical trial led by UC Davis researchers has confirmed that a new coagulation factor (rFIXFc) dramatically reduces the number of injections needed to maintain effective clotting for hemophilia B patients.

Better guidelines, coordination needed for prostate cancer specialists

December 9, 2013

With a deluge of promising new drug treatments for advanced prostate cancer on the market, a new model of care is needed that emphasizes collaboration between urologists and medical oncologists, according to UC Davis prostate cancer experts. [en español]

November 2013arrow

Health insurance increases preventive care but not risky behaviors

November 22, 2013

People with health insurance are more likely to use preventive services such as flu shots and health screenings to reduce their risk of serious illness, but they are no more likely than people without health insurance to engage in risky health behaviors such as smoking or gaining weight, researchers at UC Davis and University of Rochester have found. [en español]

October 2013arrow

Endocrine surgeon brings new expertise to UC Davis

October 23, 2013

Michael Campbell recently joined UC Davis Health System as its first fellowship-trained endocrine surgeon. Campbell specializes in the evaluation and management of patients with thyroid, parathyroid, adrenal and pancreas disorders.

Ralph de Vere White wins lifetime achievement honor

October 21, 2013

Ralph de Vere White, associate dean for cancer programs at UC Davis School of Medicine, director of the UC Davis Comprehensive Cancer Center and a distinguished professor of urology, has received the Huggins Medal Award from the Society of Urologic Oncology (SUO).

Record-breaking year for student support and alumni giving

October 2, 2013

Nearly 40,000 donors committed $149.1 million to UC Davis during the 2012-13 fiscal year, surpassing the previous year’s total of $132.4 million and marking the seventh consecutive year that philanthropic gifts exceeded $100 million.

September 2013arrow

Cancer report cites advances, need for more funding

September 17, 2013

A comprehensive report released today by the American Association for Cancer Research details progress against cancer thanks to biomedical research and advances in prevention, detection, diagnosis and treatment.

UC Davis study applies timely cost-effectiveness analysis to state breast cancer screening program

September 16, 2013

When public health budgets are constrained, mammography screening should begin later and occur less frequently, a cost-effectiveness analysis for California’s Every Woman Counts (EWC) program concludes. [en español]

UC Davis endowed chair for clinical cancer research established

September 4, 2013

Karen Kelly, Associate Director for Clinical Research at the UC Davis Comprehensive Cancer Center, is the recipient of the university’s first endowed chair in Cancer Clinical Research.

August 2013arrow

Targeting aggressive prostate cancer

August 14, 2013

A team of researchers from UC Davis, UC San Diego and other institutions has identified a key mechanism behind aggressive prostate cancer.

New support offered for people with colorectal cancer

August 12, 2013

Recently diagnosed colorectal cancer patients in the Sacramento area now have access to trained cancer peer navigators who can coach them through their treatment.

July 2013arrow

Nearly half of sarcoma surgeries done by nonsurgical oncology specialists

July 8, 2013

Orthopedic oncologists and surgical oncologists, who have been trained in the complex procedures required to remove sarcomas located deep in the muscles and other soft tissues of the limbs, conducted only 52 percent of these operations at 85 academic medical centers during a three year period, according to an analysis of national data by UC Davis researchers that is published online today in the Journal of Surgical Oncology.

June 2013arrow

Father's brain tumor treatment sparks essay, then college scholarship

June 17, 2013

A Sacramento-area college student received a $2,500 college scholarship for an essay detailing her family’s experience following her father’s brain tumor diagnosis and treatment.

Reducing unnecessary and high-dose pediatric CT scans could cut associated cancers by 62 percent

June 10, 2013

A study examining trends in X-ray computed tomography (CT) use in children in the United States has found that reducing unnecessary scans and lowering the doses for the highest-dose scans could lower the overall lifetime risk of future imaging-related cancers by 62 percent. The research by a UC Davis Health System scientist is published online today in JAMA Pediatrics. It is accompanied by a journal editorial. [en español]

May 2013arrow

Father and son to present their respective cancer research at ASCO

May 29, 2013

What started as a dinner-table conversation between a teen and his father has become a bonafide cancer research study for Matthew Lara, a Davis High School sophomore and the son of UC Davis Comprehensive Cancer Center medical oncologist and researcher Primo (Lucky) Lara Jr.

Free hepatitis B screenings offered on May 19

May 10, 2013

Asian Americans and adult children of foreign-born Asian Americans are invited to a free hepatitis B screening event Sunday, May 19 at the UC Davis Comprehensive Cancer Center.

UC Davis radiation oncology chief leads development of new prostate cancer guideline

May 7, 2013

Based on a major effort co-led by UC Davis prostate cancer expert Richard Valicenti, the nation’s leading urological and radiation oncology organizations today announced a new guideline for radiation therapy after prostatectomy.